TY - JOUR
T1 - Diagnosis and prognosis of ischemic heart disease
T2 - The framework of cardiac magnetic resonance
AU - Guaricci, Andrea Igoren
AU - Brunetti, Natale Daniele
AU - Marra, Martina Perazzolo
AU - Tarantini, Giuseppe
AU - Di Biase, Matteo
AU - Pontone, Gianluca
PY - 2015
Y1 - 2015
N2 - Cardiac magnetic resonance is considered the gold standard in the evaluation of morphology, function, viability and tissue characterization owing to its high spatial resolution and excellent signal-To-noise ratio. Its accuracy and reproducibility, also thanks to steady-state free precession sequences allowing superior bloodmyocardium delineation, are ascertained. Its current indications in the field of ischemic heart disease are multiple and continuously evolving. This technology can provide information on myocardium at risk, infarcted myocardium, microvascular obstruction and intramyocardial haemorrhage. The evaluation of each of these indexes has pivotal importance from a prognostic point of view. Rapid technological innovation engenders faster sequences and new contrast agents whereby a more accurate study of the myocardium and coronary artery disease is possible. On the contrary, there is the huge potentiality of noncontrast cardiac magnetic resonance that is especially appealing as a screening tool in asymptomatic younger patients because of radiation-free ionizing. Last but not the least, it is necessary to underline that the employment of cardiac magnetic resonance in clinical practice is restricted to few centres. This is mainly due to the need for a very high competence level and to the complexity of technical challenges required to industrial engineering, whereas the concerns expressed for its relatively high costs seem partly unfounded.
AB - Cardiac magnetic resonance is considered the gold standard in the evaluation of morphology, function, viability and tissue characterization owing to its high spatial resolution and excellent signal-To-noise ratio. Its accuracy and reproducibility, also thanks to steady-state free precession sequences allowing superior bloodmyocardium delineation, are ascertained. Its current indications in the field of ischemic heart disease are multiple and continuously evolving. This technology can provide information on myocardium at risk, infarcted myocardium, microvascular obstruction and intramyocardial haemorrhage. The evaluation of each of these indexes has pivotal importance from a prognostic point of view. Rapid technological innovation engenders faster sequences and new contrast agents whereby a more accurate study of the myocardium and coronary artery disease is possible. On the contrary, there is the huge potentiality of noncontrast cardiac magnetic resonance that is especially appealing as a screening tool in asymptomatic younger patients because of radiation-free ionizing. Last but not the least, it is necessary to underline that the employment of cardiac magnetic resonance in clinical practice is restricted to few centres. This is mainly due to the need for a very high competence level and to the complexity of technical challenges required to industrial engineering, whereas the concerns expressed for its relatively high costs seem partly unfounded.
KW - cardiac magnetic resonance
KW - contrast-enhanced MRI
KW - coronary artery disease
KW - diagnosis
KW - ischemic heart disease
KW - late gadolinium enhancement
KW - myocardial viability
KW - prognosis
UR - http://www.scopus.com/inward/record.url?scp=84949805567&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84949805567&partnerID=8YFLogxK
U2 - 10.2459/JCM.0000000000000267
DO - 10.2459/JCM.0000000000000267
M3 - Article
C2 - 25798902
AN - SCOPUS:84949805567
VL - 16
JO - Journal of Cardiovascular Medicine
JF - Journal of Cardiovascular Medicine
SN - 1558-2027
IS - 10
M1 - 16
ER -